(VIANEWS) – ABC ARBITRAGE (ABCA.PA), AXA (CS.PA), SANOFI (SAN.PA) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. ABC ARBITRAGE (ABCA.PA)
81.63% Payout Ratio
ABC arbitrage SA, together with its subsidiaries, engages in the development of arbitrage strategies for liquid assets worldwide. It develops liquidity, statistical, risk, and derivatives arbitrage strategies; and provides asset and portfolio management services. The company was incorporated in 1995 and is based in Paris, France.
Earnings Per Share
As for profitability, ABC ARBITRAGE has a trailing twelve months EPS of €0.49.
PE Ratio
ABC ARBITRAGE has a trailing twelve months price to earnings ratio of 12.06. Meaning, the purchaser of the share is investing €12.06 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.12%.
More news about ABC ARBITRAGE.
2. AXA (CS.PA)
50.66% Payout Ratio
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France, Europe, Asia, AXA XL, International, and Transversal & Central Holdings. It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products. The company also provides property and casualty insurance products, including car, home, and personal or professional liability to individual and business clients; international insurance for large corporate clients in Europe; and marine and aviation insurance services, as well as property and casualty reinsurance products. In addition, it offers asset management services in the areas of various asset classes, including equities, bonds, hedge funds, private equity, and real estate for the group's insurance companies and their clients, and retail and institutional clients. Further, the company provides health, term life, whole life, universal life, endowment, and other investment-based products for personal/individual and commercial/ group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, AXA has a trailing twelve months EPS of €2.8.
PE Ratio
AXA has a trailing twelve months price to earnings ratio of 9.45. Meaning, the purchaser of the share is investing €9.45 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.69%.
Moving Average
AXA’s worth is below its 50-day moving average of €27.60 and higher than its 200-day moving average of €24.84.
Yearly Top and Bottom Value
AXA’s stock is valued at €26.47 at 12:10 EST, under its 52-week high of €28.95 and way above its 52-week low of €20.33.
More news about AXA.
3. SANOFI (SAN.PA)
50.08% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.65.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 14.22. Meaning, the purchaser of the share is investing €14.22 for every euro of annual earnings.
More news about SANOFI.
4. PUBLICIS GROUPE SA (PUB.PA)
49.79% Payout Ratio
Publicis Groupe S.A. provides marketing, communications, and digital business transformation services in North America, Europe, the Asia Pacific, Latin America, Africa, and the Middle East. The company offers advisory services for brand strategy, and repositioning and their identity under the Publicis Worldwide, Saatchi & Saatchi, Leo Burnett, Marcel, Fallon, and BBH brands; online advertising services under the Razorfish and Moxie brand names; crisis communications, press relations, public affairs, institutional relations, financial communications, and strategy management services; media consulting, planning, and buying services; performance marketing services; and e-commerce services. It also designs and delivers brand content for various channels, such as television, print, radio, cinema, and billboards, as well as digital, including display and social networks under the Prodigious, Harbor, and The Pub brand names. In addition, the company operates Epsilon PeopleCloud, a unified data and technology platform; and Publicis Sapient, a technological, digital, and consulting platform. Further, it provides healthcare communication services under the Digitas Health, Publicis Health Media, and Saatchi & Saatchi Wellness brands for the healthcare and well-being sectors. It serves clients in the automotive, retail, financial services, consumer products, and media sectors. Publicis Groupe S.A. was founded in 1926 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PUBLICIS GROUPE SA has a trailing twelve months EPS of €4.86.
PE Ratio
PUBLICIS GROUPE SA has a trailing twelve months price to earnings ratio of 14.82. Meaning, the purchaser of the share is investing €14.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.46%.
Moving Average
PUBLICIS GROUPE SA’s worth is higher than its 50-day moving average of €71.57 and above its 200-day moving average of €67.26.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.5%, now sitting on 14.2B for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 3, 2023, the estimated forward annual dividend rate is 2.9 and the estimated forward annual dividend yield is 4.01%.
Volume
Today’s last reported volume for PUBLICIS GROUPE SA is 42242 which is 92.75% below its average volume of 582808.
More news about PUBLICIS GROUPE SA.
5. VICAT (VCT.PA)
47.41% Payout Ratio
Vicat S.A., together with its subsidiaries, engages in the production and sale of cement, ready-mixed concrete, and aggregates for construction industry. The company operates in three segments: Cement, Concrete & Aggregates, and Other Products & Services. The Cement segment offers various cement products for the general contractors, such as concrete mixers, manufacturers of precast concrete products, construction and public works contractors, local authorities, residential property developers or master masons, and construction material wholesalers or retail chains. The Concrete & Aggregates segment provides ready-mixed concrete comprising standard and special concrete for the construction and public works contractors, including construction groups, house building companies, farmers, or private individuals; and aggregates, such as sands and gravel products for the ready-mixed concrete and precast concrete products manufacturers. The Other Products & Services segment is involved in the transportation of cement, ready-mixed concrete, and aggregates; provision of construction chemicals for use in exterior wall coatings, mortar and traditional concretes, tiling adhesives, and thermal insulation products, as well as for the products used to repair floors and walls; and production of specialty papers and paper bags for the agro-food, chemical, and construction sectors. It operates in France, Switzerland, Italy, the United States, Brazil, India, Kazakhstan, Turkey, Egypt, Senegal, Mali, and Mauritania. Vicat S.A. was incorporated in 1853 and is headquartered in L'Isle-d'Abeau, France.
Earnings Per Share
As for profitability, VICAT has a trailing twelve months EPS of €3.48.
PE Ratio
VICAT has a trailing twelve months price to earnings ratio of 8.48. Meaning, the purchaser of the share is investing €8.48 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.42%.
More news about VICAT.
6. VALEO (FR.PA)
37.23% Payout Ratio
Valeo SE designs, produces, and sells components, systems, and services for automakers in France, other European countries, Africa, North America, South America, and Asia. The company operates through four segments: Comfort & Driving Assistance Systems, Powertrain Systems, Thermal Systems, and Visibility Systems. It offers parking and driving assistance products, such as ultrasonic sensors, radars, and cameras to detect obstacles around vehicles; intuitive control products; and a range of connectivity solutions from short-range to long-range connectivity, as well as develops systems that enable the integration of applications, such as car sharing services and remote parking systems. The company also provides powertrain systems, including electric powertrain systems for electric cars; torque converters, dual dry and wet clutches, and actuators that enable the automation of transmissions to reduce fuel consumption and enhance driving comfort; and clean engines for vehicles. In addition, it designs and manufactures systems, modules, and components to optimize thermal management of vehicles and passenger comfort in the cabin, including heating ventilation and air conditioning systems. Further, the company designs and produces lighting and wiper systems for drivers in various weather conditions. Additionally, it offers original equipment spares to auto manufacturers; and replacement parts and accessories to independent aftermarket for passenger cars and commercial vehicles. The company was incorporated in 1923 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, VALEO has a trailing twelve months EPS of €0.94.
PE Ratio
VALEO has a trailing twelve months price to earnings ratio of 22.18. Meaning, the purchaser of the share is investing €22.18 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.48%.
Yearly Top and Bottom Value
VALEO’s stock is valued at €20.85 at 12:10 EST, below its 52-week high of €22.23 and way higher than its 52-week low of €15.06.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.4%, now sitting on 20.04B for the twelve trailing months.
Moving Average
VALEO’s worth is way above its 50-day moving average of €18.85 and way higher than its 200-day moving average of €18.44.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 0.38 and the estimated forward annual dividend yield is 1.98%.
More news about VALEO.
